Tech Company Financing Transactions
3Z Funding Round
3Z closed a $2 million financing round on 6/20/2022. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/20/2022
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the finalization of preclinical studies on its lead therapeutic candidates in ADHD and insomnia.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Menntavegur 1
Reykjavík, 101
Iceland
Reykjavík, 101
Iceland
Phone
Website
Email Address
Overview
3Z incorporates the latest advances in disease modeling and behavioral genetics to discover novel drug candidates for CNS disorders. An innovative company which uses zebrafish to screen for neurologically effective drugs which are highly appropriate for drug repurposing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Karl Karlsson
Browse more venture capital transactions:
Prev: 6/20/2022: Platform.sh venture capital transaction
Next: 6/20/2022: Axomove venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs